European Healthtech startup funding raised during Q2 2016.
In Q2 2016, 96 European Healthtech companies raised a combined €750M across 99 funding rounds, up 143.6% versus Q2 2015. UK led by capital raised, and Bpifrance was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Oxford Nanopore Technologies | Growth/Late | Apr 2016 | €111M |
| F2G | Growth/Late | Jun 2016 | €55M |
| AC Immune | Series D+ | May 2016 | €40M |
| CRISPR Therapeutics | Series B |
8 exits · €1.2B disclosed.
| Valtech Cardio | Acquisition | Apr 2016 | €628M |
| EngMab | Acquisition | May 2016 | €545M |
| Jun 2016 |
| €35M |
| MedDay | Series B | Apr 2016 | €34M |
| Impulse Dynamics | Growth/Late | May 2016 | €30M |
| G-Therapeutics | Series A | Apr 2016 | €26M |
| STAT-Diagnostica | Series C | Apr 2016 | €25M |
| EarlySense | Series D+ | Jun 2016 | €23M |
| Allecra Therapeutics | Series B | Jun 2016 | €22M |
| apotea.se | Growth/Late | May 2016 | €22M |
| docplanner | Series C | Jun 2016 | €18M |
| Simplee | Series C | May 2016 | €18M |
| Medical Imaging Partnership | Growth/Late | May 2016 | €17M |
| Aleva Neurotherapeutics | Series C | May 2016 | €16M |
